
Canary Pharma Limited
About Canary Pharma Limited
Data last updated:
Canary Pharma Limited was a public limited company based in Indore, Madhya Pradesh, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 January 1995.
The company was registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP1995PLC008940.
The company had an authorised share capital of ₹18 Lakh and a paid-up capital of ₹18 Lakh. It was led by directors including Kiran Deshmukh and Ankit Mehta.
Its last annual general meeting (AGM) was held on 15 June 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at 12 Rajgadh Kothi Manoramaganj Behind United Tyres, Indore, Madhya Pradesh, India – 452001.
Company details
Contact details
Canary Pharma Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address12 Rajgadh Kothi Manoramaganj Behind United Tyres, Indore, Madhya Pradesh, India – 452001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Canary Pharma Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Canary Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Canary Pharma Limited, buy the company report.
Financials of Canary Pharma Limited
FY 2023 filings availableCanary Pharma Limited reported revenue of ₹4,850 (down 15% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 50% over three years, including a 15% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Canary Pharma Limited, buy the company report.
Board of directors of Canary Pharma Limited
Canary Pharma has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kiran Deshmukh Also directs: Parul Realestate LLP, Ashiyana Real Estate Developers LLP, Pitambara Infraheight LLP and 5 more | Director | 21 Jun 2006 | 20 Years 4 Months | As last reported |
| Ankit Mehta Also directs: Neptune Agricultural Investments Pvt Ltd, Sarvodaya Arts Private Limited, Kalp Vraksh Buildcon Private Limited and 5 more | Director | 12 Mar 2012 | 14 Years 8 Months | As last reported |
| Prateek Deshmukh | Director | 01 Mar 2019 | 7 Years 8 Months | As last reported |
Auditor
Canary Pharma Limited is audited by BHORKAR & KULKARNI for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BHORKAR & KULKARNI | FY 2017 | 006696C |
Shareholding
The shareholding of Canary Pharma Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Canary Pharma Limited, buy the company report.
Legal cases
No court or tribunal cases involving Canary Pharma Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Canary Pharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Canary Pharma Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Canary Pharma Limited has 8 board changes on record since 2006: 3 appointments and 5 cessations. The latest: Sanjay Mirikar ceased to be Director on 05 Mar 2019.
Frequently asked questions
Canary Pharma has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Canary Pharma was a public limited company based in Indore, Madhya Pradesh, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 17 January 1995 and is registered under CIN U24232MP1995PLC008940. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Canary Pharma is U24232MP1995PLC008940. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Canary Pharma had 3 directors:
- Kiran Deshmukh - Director
- Ankit Mehta - Director
- Prateek Deshmukh - Director
Canary Pharma was incorporated on 17 January 1995. It is registered with the Registrar of Companies, Gwalior.
The registered office of Canary Pharma is at 12 Rajgadh Kothi Manoramaganj Behind United Tyres, Indore, Madhya Pradesh, India – 452001.
The latest financial statements of Canary Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 15 June 2023. Year-wise statements from 2015 are in the company report.
Canary Pharma operated in the pharma industry, in the drug formulation and development segment.
Sanjay Mirikar ceased to be Director on 05 Mar 2019. Prateek Deshmukh was appointed as Director on 01 Mar 2019. Ankit Mehta ceased to be Additional Director on 29 Sep 2012. Canary Pharma has 8 board changes on record in total.
The compliance status of Canary Pharma is compliant as of 28 July 2026.

